Skip to main content
Start of content

ACVA Committee Report

If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.

PDF

LIST OF RECOMMENDATIONS

 

As a result of their deliberations committees may make recommendations which they include in their reports for the consideration of the House of Commons or the Government. Recommendations related to this study are listed below.

Recommendation 1

That Veterans Affairs Canada commit to recognizing the findings of the study conducted by the U.S. National Academies of Science, Engineering and Medicine, regardless of whether they strengthen or weaken the hypothesis that there is a causal link between mefloquine and certain long-term neuropsychiatric effects.

Recommendation 2

That, should the findings of the ad hoc committee of the National Academies of Science, Engineering and Medicine on the long-term effects of mefloquine justify it, Veterans Affairs Canada, together with the Department of National Defence, task an independent research organization with implementing a systematic screening program for military personnel and veterans who may be experiencing the long-term effects of mefloquine.

Recommendation 3

That Veterans Affairs Canada and the Department of National Defence recognize that certain known short-term side effects of mefloquine could have led, indirectly, to permanent disabilities among certain veterans.